亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

Non Insulin Based Type 2 Diabetes Therapy

技术优势: The inventors have developed novel molecules that have been demonstrated to be safe and effective in an animal model of diabetes (rodent) Can be taken orally unlike insulin, eliminating the need for painful injections As an a therapy which restores the body's ability to regulate blood glucose on its own, it will lead to better real time glucose management, alleviating the deleterious health effects of hyperglycemia A metabolic precursor to this molecule has been used for 5 decades to treat unrelated conditions and has proven itself to be safe and well tolerated by patients Most current therapies have adverse side effects, including hypoglycemia (low blood sugar) and weight gain, this may eliminate those

技术应用: A new, non-insulin based therapy for type 2 diabetes to aid the body's native insulin response to blood glucose levels, may be used independently or in conjunction with other therapies Use of a radiolabeled variant of the inhibitor to target beta cells in the pancreas and quantify progression of disease based on degree of labeling

详细技术说明: One of the factors contributing to type 2 diabetes is impaired beta cell function and loss of response to hyperglycemic stimulus. The invention is a novel inhibitor of an ATP dependent transporter molecule expressed in beta cells, which is responsibl...

*Inquiry: Peter GolikovColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu

*Publications: Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas, J Mol Histol. 2008 Oct;39(5):543-51

欲了解更多信息，请点击这里